Lendidip 10 mg & 20 mg FC tablet
PDF Leaflet Revision Date: 08 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension.
Dosage (summary)
Starting dose: 10 mg orally once daily before meals; may increase to 20 mg based on response.
Onset of Action / Duration
Onset: 2 weeks, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors (e.g., ketoconazole, grapefruit juice)
- Ciclosporin
- Inducers of CYP3A4 (e.g., phenytoin, rifampicin)
- Alcohol
Contraindications
- Hypersensitivity to lercanidipine
- Left ventricular outflow tract obstruction
- Untreated congestive cardiac failure
- Unstable angina pectoris
- Severe hepatic impairment
- Severe renal impairment
- Co-administration with strong CYP3A4 inhibitors
Common side effects
- Headache
- Dizziness
- Tachycardia
- Flushing
- Hypotension
Counselling Points
- Take at least 15 minutes before meals
- Avoid alcohol
- Monitor blood pressure regularly
Serious warnings
- Caution in patients with sick sinus syndrome
- Increased cardiovascular risk in ischaemic heart disease
Important Disclaimer
The Lendidip 10 mg & 20 mg FC tablet professional information leaflet below is the property of Hetero Drugs South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
